PL2801352T3 - Orally disintegrating formulations of Lacosamid - Google Patents

Orally disintegrating formulations of Lacosamid

Info

Publication number
PL2801352T3
PL2801352T3 PL14167375T PL14167375T PL2801352T3 PL 2801352 T3 PL2801352 T3 PL 2801352T3 PL 14167375 T PL14167375 T PL 14167375T PL 14167375 T PL14167375 T PL 14167375T PL 2801352 T3 PL2801352 T3 PL 2801352T3
Authority
PL
Poland
Prior art keywords
lacosamid
orally disintegrating
disintegrating formulations
formulations
orally
Prior art date
Application number
PL14167375T
Other languages
Polish (pl)
Inventor
Ali Türkyilmaz
Ali Hasan Turp
Uzunogullar Nur Kirat
Yildiz Gülkok
Mehtap Saydam
Melike Eceoglu
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret A.S. filed Critical Sanovel Ilac Sanayi Ve Ticaret A.S.
Publication of PL2801352T3 publication Critical patent/PL2801352T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
PL14167375T 2013-05-08 2014-05-07 Orally disintegrating formulations of Lacosamid PL2801352T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR201305490 2013-05-08
TR201305664 2013-05-13
EP14167375.6A EP2801352B1 (en) 2013-05-08 2014-05-07 Orally disintegrating formulations of Lacosamid

Publications (1)

Publication Number Publication Date
PL2801352T3 true PL2801352T3 (en) 2017-12-29

Family

ID=50630711

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14167375T PL2801352T3 (en) 2013-05-08 2014-05-07 Orally disintegrating formulations of Lacosamid

Country Status (4)

Country Link
EP (1) EP2801352B1 (en)
ES (1) ES2643287T3 (en)
PL (1) PL2801352T3 (en)
WO (1) WO2014180920A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018012870A2 (en) 2015-12-30 2018-12-04 Adamas Pharmaceuticals Inc methods and compositions for the treatment of crisis-related disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298947A1 (en) * 2008-05-28 2009-12-03 Pliva Hrvatska D.O.O. Polymorphic and amorphous forms of lacosamide and amorphous compositions
DE102008059155A1 (en) * 2008-11-27 2010-06-02 Ratiopharm Gmbh Dry processing and new forms of lacosamide
MX350056B (en) * 2009-11-03 2017-08-25 Lupin Ltd Modified release formulation of lacosamide.
WO2011130615A2 (en) * 2010-04-15 2011-10-20 Dr. Reddy's Laboratories Ltd. Preparation of lacosamide
EP2468261A1 (en) * 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide

Also Published As

Publication number Publication date
WO2014180920A1 (en) 2014-11-13
EP2801352B1 (en) 2017-07-05
EP2801352A1 (en) 2014-11-12
ES2643287T3 (en) 2017-11-22

Similar Documents

Publication Publication Date Title
HRP20190173T1 (en) Oral formulations of deferasirox
HK1212701A1 (en) Formulations of enzalutamide
EP3065716C0 (en) Formulations
HK1221416A1 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
IL245855A0 (en) Oral formulations of pyrrolydine derivatives
GB201319792D0 (en) Formulations
HK1201841A1 (en) Stable solid forms of regadenoson
HK1224228A1 (en) Novel formulations
HK1214951A1 (en) Ophthalimic formulations
HK1220139A1 (en) Orally disintegrating tablet
GB2516028B8 (en) Improved structure of shoe
PL2801352T3 (en) Orally disintegrating formulations of Lacosamid
PL3071575T3 (en) Preparation of normorphinans
PL2848260T3 (en) Novel formulations of thiocolchicoside
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling
GB201304608D0 (en) BenTime of Yisrael operable arrangement